Level the Playing Field for Cancer Treatment Insurance Coverage

As Congress considers the next COVID -19 relief bill, I urge New York’s federal delegation, along with House and Senate leadership to do the right thing for cancer patients and add a provision requiring oral chemotherapy drug parity. By adding language that has already been proposed and vetted in Washington, you can expand options for doctors and patients, improve the ability of cancer patients to both protect themselves and continue treatment, and provide peace of mind to those who will no longer have to choose between the risks of two terrible diseases.

Read full piece here